HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast.

Abstract
It has been established that reactive oxygen species (ROS) such as H2O2 or superoxide anion is involved in bone loss-related diseases by stimulating osteoclast differentiation and bone resorption and that receptor activator of NF-kappaB ligand (RANKL) is a critical osteoclastogenic factor expressed on stromal/osteoblastic cells. However, the roles of ROS in RANKL expression and signaling mechanisms through which ROS regulates RANKL genes are not known. Here we report that increased intracellular ROS levels by H2O2 or xanthine/xanthine oxidase-generated superoxide anion stimulated RANKL mRNA and protein expression in human osteoblast-like MG63 cell line and primary mouse bone marrow stromal cells and calvarial osteoblasts. Further analysis revealed that ROS promoted phosphorylation of cAMP response element-binding protein (CREB)/ATF2 and its binding to CRE-domain in the murine RANKL promoter region. Moreover, the results of protein kinase A (PKA) inhibitor KT5720 and CREB1 RNA interference transfection clearly showed that PKA-CREB signaling pathway was necessary for ROS stimulation of RANKL in mouse osteoblasts. In human MG63 cells, however, we found that ROS promoted heat shock factor 2 (HSF2) binding to heat shock element in human RANKL promoter region and that HSF2, but not PKA, was required for ROS up-regulation of RANKL as revealed by KT5720 and HSF2 RNA interference transfection. We also found that ROS stimulated phosphorylation of extracellular signal-regulated kinases (ERKs) and that PD98059, the inhibitor for ERKs suppressed ROS-induced RANKL expression either in mouse osteoblasts or in MG63 cells. These results demonstrate that ROS stimulates RANKL expression via ERKs and PKA-CREB pathway in mouse osteoblasts and via ERKs and HSF2 in human MG63 cells.
AuthorsXiao-chun Bai, Di Lu, An-ling Liu, Zhong-ming Zhang, Xiu-mei Li, Zhi-peng Zou, Wei-sen Zeng, Bao-luan Cheng, Shen-qiu Luo
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 280 Issue 17 Pg. 17497-506 (Apr 29 2005) ISSN: 0021-9258 [Print] United States
PMID15731115 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CREB1 protein, human
  • Carrier Proteins
  • Cyclic AMP Response Element-Binding Protein
  • DNA Primers
  • Enzyme Inhibitors
  • Flavonoids
  • Heat-Shock Proteins
  • Ligands
  • Membrane Glycoproteins
  • RANK Ligand
  • RNA, Messenger
  • Reactive Oxygen Species
  • Receptor Activator of Nuclear Factor-kappa B
  • TNFRSF11A protein, human
  • TNFSF11 protein, human
  • Tnfrsf11a protein, mouse
  • Tnfsf11 protein, mouse
  • Transcription Factors
  • HSF2 protein, human
  • Hydrogen Peroxide
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
Topics
  • Animals
  • Bone Resorption
  • Carrier Proteins (metabolism)
  • Cell Differentiation
  • Cell Line
  • Cell Line, Tumor
  • Cells, Cultured
  • Cyclic AMP (metabolism)
  • Cyclic AMP Response Element-Binding Protein (metabolism)
  • Cyclic AMP-Dependent Protein Kinases (metabolism)
  • DNA Primers (chemistry)
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors (pharmacology)
  • Flavonoids (pharmacology)
  • Flow Cytometry
  • HeLa Cells
  • Heat-Shock Proteins (metabolism)
  • Hot Temperature
  • Humans
  • Hydrogen Peroxide (pharmacology)
  • Ligands
  • Membrane Glycoproteins (metabolism)
  • Mice
  • Osteoblasts (metabolism)
  • Osteoclasts (metabolism)
  • Phosphorylation
  • Protein Structure, Tertiary
  • RANK Ligand
  • RNA Interference
  • RNA, Messenger (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Receptor Activator of Nuclear Factor-kappa B
  • Signal Transduction
  • Time Factors
  • Transcription Factors (metabolism)
  • Transfection
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: